
| Salt Composition: | Ceftriaxone (250mg) + Sulbactam (125mg) |
| Manufacturer: | Sristi Pharmaceuticals |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Riceft S 250mg/125mg Injection is a combination medicine used to treat various types of bacterial infections. It fights against microorganisms to prevent their growth and further spread of the infection. Riceft S 250mg/125mg Injection should only be administered under the supervision of a healthcare professional. Do not miss any scheduled appointments for taking this medicine. The course of the treatment must be completed even if you feel better. Sudden discontinuation of the treatment may affect the potency of the medicine. Some common side effects of this medicine are nausea, vomiting, diarrhea, indigestion, etc. If any of the side effects get aggravated, you must consult your doctor immediately. If you experience any allergic reaction (rashes, itching, swelling, shortness of breath, etc.), you must seek immediate medical help. Before taking this medicine, you should tell your doctor if you are taking any medicines for any health condition. Pregnant or breastfeeding women should also consult with their doctor before taking it. Avoid drinking alcohol as it can cause excessive drowsiness with this medicine. It usually does not impair your ability to drive, but you should not drive if it makes you feel sleepy or dizzy. You must take adequate rest for a faster recovery, also take a healthy diet and drink plenty of water. Your doctor may ask for a few laboratory and diagnostic tests to know the effects of the medicine on your body.
Riceft S 250mg/125mg Injection is a combination of two medicines: Ceftriaxone and Sulbactam. Ceftriaxone is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Sulbactam is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Ceftriaxone against bacteria.
Does Riceft S 250mg/125mg Injection carry an allergy risk?
Yes, Riceft S 250mg/125mg Injection can trigger allergic reactions and is contraindicated for patients with known cephalosporin allergies. Seek immediate medical attention if you experience any signs of an allergic reaction such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.
Does Riceft S 250mg/125mg Injection cause diarrhea?
Yes, Riceft S 250mg/125mg Injection can cause diarrhea. As an antibiotic that targets harmful bacteria, it can also disrupt the beneficial bacteria in your stomach or intestines, leading to diarrhea. If you experience severe diarrhea, consult with your doctor for guidance.
How long does Riceft S 250mg/125mg Injection take to become effective?
Typically, Riceft S 250mg/125mg Injection starts working shortly after administration. However, complete elimination of harmful bacteria and symptom relief may take several days.
What should I do if I don't feel better after using Riceft S 250mg/125mg Injection?
If you don't experience improvement after completing the full course of treatment, consult your doctor. Also, report any worsening symptoms to your physician.
Can I stop Riceft S 250mg/125mg Injection prematurely if I feel better?
No, it's crucial not to discontinue using Riceft S 250mg/125mg Injection before completing the full course. Continued treatment is necessary even if symptoms improve to ensure complete eradication of the infection.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Alcohol
Consuming alcohol with Riceft S 250mg/125mg Injection does not cause any harmful side effects.
Breastfeed
Riceft S 250mg/125mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Pregnancy
Riceft S 250mg/125mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.